Dec 01, 2025
The metastatic colorectal cancer drug treatment landscape has advanced considerably, with a growing range of targeted therapies, immunotherapies, and innovative agents now complementing standard chemotherapy. The mCRC treatment paradigm is structured across multiple lines of therapy. First-line (1L) treatment typic...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper